Cargando…

Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control

Intact and broad immune cell effector functions and specific individual cytokines have been linked to HIV disease outcome, but their relative contribution to HIV control remains unclear. We asked whether the proteome of secreted cytokines and signaling factors in peripheral blood can be used to disc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Riol, M., Berdnik, D., Llano, A., Mothe, B., Gálvez, C., Pérez-Álvarez, S., Oriol-Tordera, B., Olvera, A., Silva-Arrieta, S., Meulbroek, M., Pujol, F., Coll, J., Martinez-Picado, J., Ganoza, C., Sanchez, J., Gómez, G., Wyss-Coray, T., Brander, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533920/
https://www.ncbi.nlm.nih.gov/pubmed/28592538
http://dx.doi.org/10.1128/JVI.00441-17
_version_ 1783253690030751744
author Ruiz-Riol, M.
Berdnik, D.
Llano, A.
Mothe, B.
Gálvez, C.
Pérez-Álvarez, S.
Oriol-Tordera, B.
Olvera, A.
Silva-Arrieta, S.
Meulbroek, M.
Pujol, F.
Coll, J.
Martinez-Picado, J.
Ganoza, C.
Sanchez, J.
Gómez, G.
Wyss-Coray, T.
Brander, C.
author_facet Ruiz-Riol, M.
Berdnik, D.
Llano, A.
Mothe, B.
Gálvez, C.
Pérez-Álvarez, S.
Oriol-Tordera, B.
Olvera, A.
Silva-Arrieta, S.
Meulbroek, M.
Pujol, F.
Coll, J.
Martinez-Picado, J.
Ganoza, C.
Sanchez, J.
Gómez, G.
Wyss-Coray, T.
Brander, C.
author_sort Ruiz-Riol, M.
collection PubMed
description Intact and broad immune cell effector functions and specific individual cytokines have been linked to HIV disease outcome, but their relative contribution to HIV control remains unclear. We asked whether the proteome of secreted cytokines and signaling factors in peripheral blood can be used to discover specific pathways critical for host viral control. A custom glass-based microarray, able to measure >600 plasma proteins involved in cell-to-cell communication, was used to measure plasma protein profiles in 96 HIV-infected, treatment-naive individuals with high (>50,000) or low (<10,000 HIV RNA copies/ml) viral loads. Univariate and regression model analysis demonstrate that plasma levels of soluble interleukin-27 (IL-27) are significantly elevated in individuals with high plasma viremia (P < 0.0001) and are positively correlated with proviral HIV-DNA copy numbers in peripheral blood mononuclear cells (PBMC) (Rho = 0.4011; P = 0.0027). Moreover, soluble IL-27 plasma levels are negatively associated with the breadth and magnitude of the total virus-specific T-cell responses and directly with plasma levels of molecules involved in Wnt/β-catenin signaling. In addition to IL-27, gene expression levels of the specific IL-27 receptor (IL27RA) in PBMC correlated directly with both plasma viral load (Rho = 0.3531; P = 0.0218) and the proviral copy number in the peripheral blood as an indirect measure of partial viral reservoir (Rho = 0.4580; P = 0.0030). These results were validated in unrelated cohorts of early infected subjects as well as subjects before and after initiation of antiretroviral treatment, and they identify IL-27 and its specific receptor as a critical immune axis for the antiviral immune response and as robust correlates of viral load and proviral reservoir size in PBMC. IMPORTANCE The detailed knowledge of immune mechanisms that contribute to HIV control is a prerequisite for the design of effective treatment strategies to achieve HIV cure. Cells communicate with each other by secreting signaling proteins, and the blood is a key conduit for transporting such factors. Investigating the communication factors promoting effective immune responses and having potentially antiviral functions against HIV using a novel focused omics approach (“communicome”) has the potential to significantly improve our knowledge of effective host immunity and accelerate the HIV cure agenda. Including 140 subjects with variable viral loads and measuring the plasma levels of >600 soluble proteins, our data highlight the importance of Th17 cells and Wnt/β-catenin signaling in HIV control and especially identify the IL-27/IL-27 receptor subunit alpha (IL-27RA) axis as a predictor of plasma viral load and proviral copy number in the peripheral blood. These data may provide important guidance to therapeutic approaches in the HIV cure agenda.
format Online
Article
Text
id pubmed-5533920
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-55339202017-08-08 Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control Ruiz-Riol, M. Berdnik, D. Llano, A. Mothe, B. Gálvez, C. Pérez-Álvarez, S. Oriol-Tordera, B. Olvera, A. Silva-Arrieta, S. Meulbroek, M. Pujol, F. Coll, J. Martinez-Picado, J. Ganoza, C. Sanchez, J. Gómez, G. Wyss-Coray, T. Brander, C. J Virol Pathogenesis and Immunity Intact and broad immune cell effector functions and specific individual cytokines have been linked to HIV disease outcome, but their relative contribution to HIV control remains unclear. We asked whether the proteome of secreted cytokines and signaling factors in peripheral blood can be used to discover specific pathways critical for host viral control. A custom glass-based microarray, able to measure >600 plasma proteins involved in cell-to-cell communication, was used to measure plasma protein profiles in 96 HIV-infected, treatment-naive individuals with high (>50,000) or low (<10,000 HIV RNA copies/ml) viral loads. Univariate and regression model analysis demonstrate that plasma levels of soluble interleukin-27 (IL-27) are significantly elevated in individuals with high plasma viremia (P < 0.0001) and are positively correlated with proviral HIV-DNA copy numbers in peripheral blood mononuclear cells (PBMC) (Rho = 0.4011; P = 0.0027). Moreover, soluble IL-27 plasma levels are negatively associated with the breadth and magnitude of the total virus-specific T-cell responses and directly with plasma levels of molecules involved in Wnt/β-catenin signaling. In addition to IL-27, gene expression levels of the specific IL-27 receptor (IL27RA) in PBMC correlated directly with both plasma viral load (Rho = 0.3531; P = 0.0218) and the proviral copy number in the peripheral blood as an indirect measure of partial viral reservoir (Rho = 0.4580; P = 0.0030). These results were validated in unrelated cohorts of early infected subjects as well as subjects before and after initiation of antiretroviral treatment, and they identify IL-27 and its specific receptor as a critical immune axis for the antiviral immune response and as robust correlates of viral load and proviral reservoir size in PBMC. IMPORTANCE The detailed knowledge of immune mechanisms that contribute to HIV control is a prerequisite for the design of effective treatment strategies to achieve HIV cure. Cells communicate with each other by secreting signaling proteins, and the blood is a key conduit for transporting such factors. Investigating the communication factors promoting effective immune responses and having potentially antiviral functions against HIV using a novel focused omics approach (“communicome”) has the potential to significantly improve our knowledge of effective host immunity and accelerate the HIV cure agenda. Including 140 subjects with variable viral loads and measuring the plasma levels of >600 soluble proteins, our data highlight the importance of Th17 cells and Wnt/β-catenin signaling in HIV control and especially identify the IL-27/IL-27 receptor subunit alpha (IL-27RA) axis as a predictor of plasma viral load and proviral copy number in the peripheral blood. These data may provide important guidance to therapeutic approaches in the HIV cure agenda. American Society for Microbiology 2017-07-27 /pmc/articles/PMC5533920/ /pubmed/28592538 http://dx.doi.org/10.1128/JVI.00441-17 Text en Copyright © 2017 Ruiz-Riol et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Pathogenesis and Immunity
Ruiz-Riol, M.
Berdnik, D.
Llano, A.
Mothe, B.
Gálvez, C.
Pérez-Álvarez, S.
Oriol-Tordera, B.
Olvera, A.
Silva-Arrieta, S.
Meulbroek, M.
Pujol, F.
Coll, J.
Martinez-Picado, J.
Ganoza, C.
Sanchez, J.
Gómez, G.
Wyss-Coray, T.
Brander, C.
Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control
title Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control
title_full Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control
title_fullStr Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control
title_full_unstemmed Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control
title_short Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control
title_sort identification of interleukin-27 (il-27)/il-27 receptor subunit alpha as a critical immune axis for in vivo hiv control
topic Pathogenesis and Immunity
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533920/
https://www.ncbi.nlm.nih.gov/pubmed/28592538
http://dx.doi.org/10.1128/JVI.00441-17
work_keys_str_mv AT ruizriolm identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT berdnikd identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT llanoa identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT motheb identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT galvezc identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT perezalvarezs identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT orioltorderab identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT olveraa identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT silvaarrietas identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT meulbroekm identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT pujolf identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT collj identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT martinezpicadoj identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT ganozac identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT sanchezj identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT gomezg identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT wysscorayt identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol
AT branderc identificationofinterleukin27il27il27receptorsubunitalphaasacriticalimmuneaxisforinvivohivcontrol